Saram ConsultingGxP & AI Consulting for Life Sciences. Custom AI integrations, Part 11 compliance validation, and equity-based engineering partnerships for biotech.Explore Services at saram.io →
← Back to Home

Kyntra Bio

Kyntra Bio is the San Francisco biopharmaceutical company formerly known as FibroGen, focused on oncology and anemia therapies after a series of late-stage clinical and regulatory setbacks. Its HIF-PHI roxadustat is approved in several markets outside the United States.

Company Info

Sector:Biopharmaceuticals
Headquarters:San Francisco, CA, USA
Founded:1993

Clinical Development Pipeline

Roxadustat

Target: HIF prolyl hydroxylase inhibitor
Anemia of chronic kidney disease
Preclinical
Phase 1
Phase 2
Phase 3
Approved

Pamrevlumab

Target: CTGF (connective tissue growth factor)
Pancreatic cancer and fibrotic disease
Preclinical
Phase 1
Phase 2
Phase 3
Approved

Recent News

Leadership Team

Careers & Job Openings

See all open roles

Clinical / Corporate
San Francisco, CA
Apply Now →